194 related articles for article (PubMed ID: 3039510)
1. Amplification and deregulation of MYC following Epstein-Barr virus infection of a human B-cell line.
Lacy J; Summers WP; Watson M; Glazer PM; Summers WC
Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5838-42. PubMed ID: 3039510
[TBL] [Abstract][Full Text] [Related]
2. Post-transcriptional mechanisms of deregulation of MYC following conversion of a human B cell line by Epstein-Barr virus.
Lacy J; Summers WP; Summers WC
EMBO J; 1989 Jul; 8(7):1973-80. PubMed ID: 2551670
[TBL] [Abstract][Full Text] [Related]
3. Oncogene expression in isogenic, EBV-positive and -negative Burkitt lymphoma cell lines.
Glazer PM; Summers WC
Intervirology; 1985; 23(2):82-9. PubMed ID: 2984143
[TBL] [Abstract][Full Text] [Related]
4. Conversion of the lymphoma line "BJAB" by Epstein-Barr virus into phenotypically altered sublines is accompanied by increased c-myc mRNA levels.
Wennborg A; Aman P; Saranath D; Pear W; Sümegi J; Klein G
Int J Cancer; 1987 Aug; 40(2):202-6. PubMed ID: 3038758
[TBL] [Abstract][Full Text] [Related]
5. Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA.
Clements GB; Klein G; Povey S
Int J Cancer; 1975 Jul; 16(1):125-33. PubMed ID: 170210
[TBL] [Abstract][Full Text] [Related]
6. c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.
Polack A; Hörtnagel K; Pajic A; Christoph B; Baier B; Falk M; Mautner J; Geltinger C; Bornkamm GW; Kempkes B
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10411-6. PubMed ID: 8816814
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic rearrangement of C-MYC oncogene occurs prior to infection with Epstein-Barr virus in the monoclonal malignant B cells from an AIDS patient.
Roncella S; Di Celle PF; Cutrona G; Carbone A; Sessarego M; Landonio G; Foà R; Rowe M; Ferrarini M
Leuk Lymphoma; 1993 Jan; 9(1-2):157-64. PubMed ID: 8386576
[TBL] [Abstract][Full Text] [Related]
8. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
[TBL] [Abstract][Full Text] [Related]
9. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5.
Trivedi P; Cuomo L; de Campos-Lima PO; Imreh MP; Kvarnung K; Klein G; Masucci MG
J Gen Virol; 1993 Jul; 74 ( Pt 7)():1393-8. PubMed ID: 8393080
[TBL] [Abstract][Full Text] [Related]
10. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus and Burkitt's lymphoma.
Magrath I; Jain V; Bhatia K
Semin Cancer Biol; 1992 Oct; 3(5):285-95. PubMed ID: 1335792
[TBL] [Abstract][Full Text] [Related]
12. Parallel existence of Epstein-Barr virus (EBV) positive and negative cells in a sporadic case of Burkitt lymphoma.
Trivedi P; Zhang QJ; Chen F; Minarovits J; Ekman M; Biberfeld P; Klein G; Winberg G
Oncogene; 1995 Aug; 11(3):505-10. PubMed ID: 7630634
[TBL] [Abstract][Full Text] [Related]
13. Primary EBV infection of human umbilical cord lymphocytes and EBV genome-negative lymphoblastoid cell lines (BJAB and Ramos).
Takimoto T; Sato H; Ogura H
Auris Nasus Larynx; 1986; 13(3):199-205. PubMed ID: 3036055
[TBL] [Abstract][Full Text] [Related]
14. MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.
Staege MS; Lee SP; Frisan T; Mautner J; Scholz S; Pajic A; Rickinson AB; Masucci MG; Polack A; Bornkamm GW
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4550-5. PubMed ID: 11917131
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.
Kelly G; Bell A; Rickinson A
Nat Med; 2002 Oct; 8(10):1098-104. PubMed ID: 12219084
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus gene expression during primary B-lymphocyte infection, in transformed and Burkitt lymphoma-derived cell lines.
Ernberg I; Kallin B; Dillner J
Curr Top Microbiol Immunol; 1986; 132():251-6. PubMed ID: 3024918
[No Abstract] [Full Text] [Related]
17. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
Gregory CD; Rowe M; Rickinson AB
J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
[TBL] [Abstract][Full Text] [Related]
18. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
Doyle MG; Crawford DH
Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878
[TBL] [Abstract][Full Text] [Related]
19. Expression of Epstein-Barr virus latent infection genes and oncogenes in lymphoma cell lines derived from pyothorax-associated lymphoma.
Kanno H; Yasunaga Y; Ohsawa M; Taniwaki M; Iuchi K; Naka N; Torikai K; Shimoyama M; Aozasa K
Int J Cancer; 1996 Jul; 67(1):86-94. PubMed ID: 8690530
[TBL] [Abstract][Full Text] [Related]
20. Constitutive activation of oncogenes by chromosomal translocations in B-cell derived tumors.
Klein G
AIDS Res; 1986 Dec; 2 Suppl 1():S167-76. PubMed ID: 3030345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
